at Google ScholarTitle data
Nagels, Klaus:
Entrectinib, Larotrectinib : Was ist für die Translation der agnostischen Tumortherapie in die Versorgung notwendig?
In: Market Access & Health Policy.
Vol. 9
(January 2021)
.
ISSN 2195-2515
Further data
| Item Type: | Article in a journal |
|---|---|
| Refereed: | Yes |
| Institutions of the University: | Faculties > Faculty of Law, Business and Economics > Chair Healthcare Management and Research > Chair Healthcare Management and Research - Univ.-Prof. Dr. Klaus Nagels Faculties Faculties > Faculty of Law, Business and Economics Faculties > Faculty of Law, Business and Economics > Chair Healthcare Management and Research |
| Result of work at the UBT: | Yes |
| DDC Subjects: | 300 Social sciences > 300 Social sciences, sociology and anthropology 300 Social sciences > 330 Economics 600 Technology, medicine, applied sciences > 600 Technology 600 Technology, medicine, applied sciences > 610 Medicine and health |
| Date Deposited: | 01 Feb 2021 08:15 |
| Last Modified: | 01 Feb 2021 08:15 |
| URI: | https://eref.uni-bayreuth.de/id/eprint/62611 |